RAFAEL HOLDINGS, INC. Deferred Income Tax Assets, Net
RAFAEL HOLDINGS, INC. (RFL) had Deferred Income Tax Assets, Net of $7.50 million as of 2021-07-31, per its 10-K filed 2022-10-31.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2022-10-31
- 2021-07-31: Deferred Income Tax Assets, Net $7.50M.
- 2020-07-31: Deferred Income Tax Assets, Net $6.00K.
- 2019-07-31: Deferred Income Tax Assets, Net $19.00K.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2021-07-31 | $7.50M 10-K · filed 2022-10-31 |
| 2020-07-31 | $6.00K 10-K · filed 2021-10-18 |
| 2019-07-31 | $19.00K 10-K · filed 2020-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |